Stanley Druckenmiller – NAMS history
- Issuer:
- Newamsterdam Pharma Company
- Quarters tracked:
- 7 (Q3 2024 → Q1 2026)
- Current shares:
- 3,070,146
- Current value:
- $98.28M
- Peak shares:
- 3,070,146 (Q4 2025)
- Overall change:
- +968%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 3,070,146 | $98.28M | $32.01 | 0 | 0% |
| Q4 2025 | 3,070,146 | $107.70M | $35.08 | +1,146,446 | +60% |
| Q3 2025 | 1,923,700 | $54.71M | $28.44 | +1,091,525 | +131% |
| Q2 2025 | 832,175 | $15.07M | $18.11 | +31,815 | +4% |
| Q1 2025 | 800,360 | $16.38M | $20.47 | +512,825 | +178% |
| Q4 2024 | 287,535 | $7.39M | $25.70 | 0 | 0% |
| Q3 2024 | 287,535 | $4.77M | $16.60 | — | NEW |